Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$921K Sell
49,183
-905
-2% -$18.2K ﹤0.01% 1229
2026
Q2
$937K Buy
50,088
+25,018
+100% +$499K ﹤0.01% 911
2026
Q1
$472K Buy
25,070
+2,785
+12% +$52.3K ﹤0.01% 942
2025
Q4
$348K Buy
22,285
+3,201
+17% +$47.5K ﹤0.01% 982
2025
Q3
$253K Sell
19,084
-2,251
-11% -$29.1K ﹤0.01% 1119
2025
Q2
$265K Buy
21,335
+5,115
+32% +$64.4K ﹤0.01% 1001
2025
Q1
$247K Buy
16,220
+220
+1% +$3.29K ﹤0.01% 919
2024
Q4
$234K Buy
+16,000
New +$250K ﹤0.01% 1242
2024
Q3
– Sell
-14,607
Closed -$278K – 1443
2024
Q2
$278K Buy
+14,607
New +$274K ﹤0.01% 1009

Other funds holding NOV

Savant Capital's NOV Position: Q3 2026 in Review

Savant Capital reduced its NOV (NOV) stake by 1.8% in Q3 2026, selling an estimated $18.2K and leaving 49,183 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #1229.

Savant Capital first reported a position in NOV in Q2 2024 and has held it in 9 quarters since. The position peaked at $937K in Q2 2026. 497 funds tracked by Wall St. Rank hold NOV as of Q3 2026.

  • Savant Capital held 49,183 shares of NOV worth $921K as of Q3 2026.
  • Savant Capital sold 905 NOV shares in Q3 2026, an estimated $18.2K.
  • NOV made up ﹤0.01% of Savant Capital's portfolio in Q3 2026, its #1229 holding.
  • Savant Capital first reported a position in NOV in Q2 2024 and has held it in 9 quarters since.
  • Savant Capital's NOV position peaked at $937K in Q2 2026.
  • 497 funds tracked by Wall St. Rank held NOV as of Q3 2026.

Based on Savant Capital's 13F filing for Q3 2026, filed 6 Nov 2026.